Publications

Search our bibliography using the filters on the right-hand side.

Displaying 251 through 300 of 325 publications.

Davis KL, Candrilli SD, Manjunath R. Adherence with antiepileptic drugs and associated impact on time to seizure in adolescents diagnosed with epilepsy. Poster presented at the Annual Meeting of the Child Neurology Society; October 2007.

Candrilli SD, Davis KL, Kan HJ, Lucero MA, Rousculp MD. Prevalence and the associated burden of illness of symptoms of diabetic peripheral neuropathy and diabetic retinopathy. J Diabetes Complications. 2007 Oct 1;21(5):306-14.

Berger A, Dukes E, Martin SA, Edelsberg J, Oster G. Characteristics and healthcare costs of patients with FMS. Int J Clin Pract. 2007 Sep 1;61(9):1498-508.

McAfee AT, Chilcott KE, Johannes CB, Hornbuckle K, Hauser WA, Walker AM. The incidence of first provoked and unprovoked seizure in pediatric patients with and without psychiatric diagnoses. Epilepsia. 2007 Jun 1;48(6):1075-82.

Doward LC, McKenna SP, Meads DM, Twiss J, Hagell P, Oprandi N. Psychometric and scaling properties of the patient reported outcome indices for multiple sclerosis (PRIMUS). Mult Scler. 2007 Jun;13(Suppl 2):S219.

McLeod LD, Fehnel SE, Zografos LJ, Sander S, Curtice T, Shah H. The impact of restless legs syndrome on diagnosed and undiagnosed sufferers: results of a web-based patient survey. Poster presented at the SLEEP 2007 21st Annual Meeting of the Associated Professional Sleep Societies; June 2007.

Mease P, Arnold LM, Bennett R, Boonen A, Buskila D, Carville S, Chappell A, Choy E, Clauw D, Dadabhoy D, Gendreau M, Goldenberg D, Littlejohn G, Martin SA. OMERACT 8 workshop: fibromyalgia syndrome. J Rheumatol. 2007 Jun;34(6):1415-25.

Mitra D, Davis KL, Baran R. Health care utilization and costs associated with constipation (C-ONLY) and co-occurring irritable bowel syndrome and constipation (IBS+C) compared to migraine in a large managed care population. Poster presented at the 2007 ISPOR 12th Annual International Meeting; May 22, 2007. [abstract] Value Health. 2007 May; 10(3):A148-9.

McLeod LD, Fehnel SE, Zografos LJ, Sander SD, Curtis TG, Shah H. The impact of restless legs syndrome on various dimensions of life: results of a web-based patient survey. Poster presented at the 2007 ISPOR 12th Annual International Meeting; May 22, 2007. [abstract] Value Health. 2007 May; 10(3):A95.

Mahajan S, Fehnel SE, Thompson M, Minnich M, Northcutt A, Bell T. Comparing the effects of irritable bowel syndrome on work productivity and healthcare utilization with those of asthma and migraine: results from a web-based patient survey. Presented at the 2007 Digestive Disease Week; May 1, 2007.

Davis KL, Candrilli SD, Edin HM. Prevalence and cost impact of nonadherence with antiepilepsy drugs among adults in a managed care population. Poster presented at the Academy of Managed Care Pharmacy 19th Annual Meeting Showcase; April 14, 2007.

Bell C, Graham JB, Earnshaw S, Oleen-Burkey MK, Castelli-Haley J, Johnson K. Cost-effectiveness of four immunomodulatory therapies for relapsing-remitting multiple sclerosis: a Markov model based on long-term clinical data. J Manag Care Pharm. 2007 Apr 1;13(3):245-61.

Ehrenstein V, Pedersen L, Holsteen V, Larsen H, Rothman KJ, Sorensen HT. Postterm delivery and risk of epilepsy in childhood. Pediatrics. 2007 Mar 30;119(3):e554-61.

Mines D, Gu Y, Novelli L, Lui Q, Gelfand J. Risk of CNS demyelinating diseases among patients with psoriasis and rheumatoid arthritis. Poster presented at the 2007 59th Annual Meeting of the American Academy of Neurology; May 2007. Boston, MA. [abstract] Neurology. 2007; 68(12, Suppl 1):A165.

McCrink L, Allen RP, Wolowacz SE, Sherrill B, Connolly M, Kirsch J. Predictors of health-related quality of life in sufferers with restless legs syndrome: a multi-national study. Sleep Med. 2007 Jan 1;8(1):73-83.

Wilson MR, Van Houtven CH, Stearns S, Clipp EC. Depression and missed work among informal caregivers of older individuals with dementia. J Fam Econ Issues. 2007;28(4):684-98.

Burch SP, Davis KH, Fehnel SE, Nelsen AC, Hill CD, Shashidhar KH. Outcomes, impact and behavior associated with acute treatment of migraine. Poster presented at the 16th Migraine Trust International Symposium; November 2006. [abstract] Cephalalgia. 2006 Nov; 26(11):1358-403.

Davis KL, Allen JK, Kirsch J, Davis KH, Edin HM. The prevalence of treatment non-adherence among patients with parkinson's disease in a United States managed care population. Poster presented at the 10th Congress of the European Federation of Neurological Societies; September 5, 2006.

Burch SP, Davis KH, Fehnel SE, Nelsen AC, Hill CD, Kori SH. The migraine assessment of current therapy (Migraine-ACT): a useful tool for detecting differences in outcomes between migraine therapies. Poster presented at the Migraine Trust International Symposium; September 2006.

Cole JA, Rothman KJ, Cabral HJ, Zhang Y, Farraye FA. Migraine, fibromyalgia, and depression among people with IBS: a prevalence study. BMC Gastroenterol. 2006 Sep 1;6(26).

Van Houtven CH, Wilson MR, Stearns SC, Clipp E. Depression and missed work among informal caregivers of older individuals with dementia. Poster presented at the AcademyHealth 2006 Annual Research Meeting; June 2006.

Bell CF, Graham JB, Earnshaw SR, Oleen-Burkey M, Castelli-Haley J, Johnson K. Assessing the cost-effectiveness of immunomodulatory therapies for relapsing-remitting multiple sclerosis based on long-term data. Poster presented at the 2006 ISPOR 11th Annual International Meeting; May 20, 2006. Philadelphia, PA.

Bell CF, Graham JB, Earnshaw SR, Oleen-Burkey M, Castelli-Haley J, Johnson KP. Assessing the cost-effectiveness of immunomodulatory therapies for relapsing-remitting multiple sclerosis based on long-term data. Value Health. 2006 May 1;9(3):A81-2.

Mladsi DM, Barrett AM. Winners and losers: patterns in economic evaluations of anti-epileptic drugs. Poster presented at the 2006 ISPOR 11th Annual International Meeting; May 20, 2006. Philadelphia, PA. [abstract] Value Health. 2006 May; 9(3):A83.

MacMahon B, Rothman KJ. Anencephaly and twins. Prenat Diagn. 2006 Apr 1;26(4):380-1.

Ehrenstein V, Sorensen HT, Pedersen L, Larsen H, Holsteen V, Rothman KJ. Apgar score and hospitalization for epilepsy in childhood: a registry-based cohort study. BMC Public Health. 2006 Feb 1;6:23.

Doward LC, McKenna SP, Meads DM, Jovell AJ, Fisk J, Eckert BJ. The international development of patient reported outcome indices for multiple sclerosis. Poster presented at the 2006 Sixteenth Meeting of the European Neurological Society; May 2006. Lausanne, Switzerland. [abstract] J Neurol. 2006; 253(Suppl 2):125.

Moncrief C, Rosamond W. Stroke symptom awareness and urgency. Stroke Notes. 2005 Dec;11:5.

Doward LC, McKenna SP, Meads DM, Kavyasiddhi D, Hampson NE, Mayo KW. The symptomatic, functional and quality of life impact of multiple sclerosis: report on a qualitative investigation of the patients' perspective. Poster presented at the 2005 ISPOR 8th Annual European Congress; November 2005. Florence, Italy. [abstract] Value Health. 2005 Nov; 8(6):A135.

Davis KL, Candrilli SD, Kan H, Lucero MA, Covington M. Estimating the effects of diabetic peripheral neuropathy and diabetic retinopathy on quality-of-life using data from the 2001-2002 national health and nutrition examination survey. Poster presented at the 2005 ISPOR 10th Annual International Meeting; May 18, 2005. [abstract] Value Health. 2005 May; 8(3):365.

Davis KL, Candrilli SD, Kan HJ, Lucero MA, Covington MT. Estimating the effect of symptoms of diabetic peripheral neuropathy and diabetic retinopathy on quality-of-life using data from the 2001-2002 national health and nutrition examination survey. Poster presented at the 2005 ISPOR 10th Annual International Meeting; May 2005. Washington, DC. [abstract] Value Health. 2005 May; 8(3):365.

Candrilli SD, Davis KL, Kan H, Lucero MA, Covington M. Burden of illness associated with symptoms of diabetic peripheral neuropathy and diabetic retinopathy. Poster presented at the 2005 ISPOR 10th Annual International Meeting; May 18, 2005. [abstract] Value Health. 2005 May; 8(3):357.

Morgan L, Hawe E, Palmen J, Montgomery H, Humphries SE, Kitchen N. Polymorphism of the heme oxygenase-1 gene and cerebral aneurysms. Br J Neurosurg. 2005;19(4):317-21.

Fischer T, Johnsen SP, Pedersen L, Gaist D, Sorensen HT, Rothman KJ. Seasonal variation in hospitalization and case fatality of subarachnoid hemorrhage - A nationwide Danish study on 9,367 patients. Neuroepidemiology. 2005 Jan 1;24(1-2):32-7.

Gaffney L, Sherrill EH, Wolowacz SE, Allen R, Connolly M. Predictors of health-related quality of life (HRQoL) in US patients suffering from rls. Poster presented at the International Congress on Parkinson's Disease and Movement Disorders; 2005.

Gaffney L, Sherrill B, Wolowacz SE, Allen R, Connolly M, Kirsch J. Evaluating the predictors of health-related quality of life in European respondents with restless legs syndrome. Poster presented at the ICPD meeting; 2005; 2005. Berlin, Germany.

Barrows SM, Brown MT. Effect of valdecoxib on functional impairment, quality of life and patient satisfaction in migraine patients. Poster presented at the Annual Meeting of the American College of Nurse Practitioners; October 2004.

Ervin CM. The North Carolina collaborative stroke registry. Poster presented at the North Carolina Stroke Association Annual Convention; October 2004.

Mines D, Novelli L. The risk of first seizure associated with mefenamic acid in women of reproductive age. Poster presented at the 2004 20th International Conference on Pharmacoepidemiology; August 2004. Bordeaux, France. [abstract] Pharmacoepidemiol Drug Saf. 2004 Sep 23; 13(S1).

Hauber BHIV, Candrilli SD, Snyder EG, McBurney CR. Validation of a model to assess long-term disease progression in alzheimer's disease patients treated with rivastigmine. Poster presented at the 9th International Conference on Alzheimer's Disease and Related Disorders; July 2004.

Rebordosa C, Aguilera C. Safety of antiepileptic drugs during pregnancy. Med Clin (Barc). 2004 May 8;122(17):675-6.

Hauber B, Candrilli S, Snyder EH, McBurney CR. Validation of a model to assess long-term disease progression in Alzheimer's disease patients treated with rivastigmine. Neurobiol Aging. 2004 Jan 1;25:S136.

Beard SM, Gaffney L, Bamber L. Economic modelling of antiplatelet therapy in the secondary prevention of stroke. Poster presented at the 2003 ISPOR 6th Annual European Congress; November 9, 2003. Barcelona, Spain.

Neighbors DM, McCory D, Pesa J. Cost-effectiveness and budget impact of zolmitriptan nasal spray. Poster presented at the 2003 AMCP Educational Conference; October 2003. Montreal, Canada.

Rowland CR, Barrows SM, Brown MT. Effects of valdecoxib on functional impairment, quality of life and treatment satisfaction in migraine patients. Poster presented at the Annual Meeting of the International Headache Society; September 2003.

Granger AL, Fehnel SE, Bell T. Humanistic and financial impacts of restless legs syndrome form the patients' perspective. Poster presented at the 7th Congress of the European Federation of Neurological Societies; August 2003.

Hagell P, Whalley D, McKenna SP, Lindvall 0. Health status measurement in Parkinson's disease: validity of the PDQ-39 and Nottingham Health Profile. Mov Disord. 2003 Jul 1;18(7):773-83.

Beard S, Gaffney L, Bamber L. Economic modelling of antiplatelet therapy in the prevention of recurrent stroke. Value Health. 2003 Jan 1;6(6):650.

Rosamond WD, Goldstein L, Felix A, Evenson K, Moncrief C. The North Carolina collaborative stroke registry: design and first year experience. Poster presented at the International Stroke Conference; 2003.

Rosamond WD, Goldstein L, Felix A, Evenson K, Asimos A, Moncrief C. The North Carolina collaborative stroke registry: a Paul Coverdell stroke registry. Poster presented at the Tri-State Stroke Network Annual Conference; 2003.